Case Reports

Leukocytoclastic Vasculitis Masquerading as Chronic ITP

Author and Disclosure Information

Background: Idiopathic thrombocytopenic purpura (ITP) and leukocytoclastic vasculitis (LCV) can present in a similar fashion and can be very hard to differentiate them clinically without a biopsy. This can cause diagnostic dilemma and delay in management. A thorough evaluation is recommended to determine etiology, although about half are idiopathic.

Case Presentation: A patient aged 79 years with long-standing thrombocytopenia secondary to chronic ITP presented with a rash. Although it was thought to be secondary to ITP, a biopsy revealed presence of leukocytoclastic vasculitis.

Conclusions: Although most LCV cases are mild and resolve without intervention, many go undiagnosed due to biopsy delays. Health care professionals should determine and treat the underlying cause.


 

References

Idiopathic thrombocytopenic purpura (ITP) is an immune-mediated acquired condition affecting both adults and children.1 Acute ITP is the most common form, which happens in the presence of a precipitant, leading to a drop in platelet counts. However, chronic ITP can occur when all the causes that might precipitate thrombocytopenia have been ruled out, and it is persistent for ≥ 12 months.2 Its presence can mask other diseases that exhibit somewhat similar signs and symptoms. We present a case of a patient presenting with chronic ITP with diffuse rash and was later diagnosed with idiopathic leukocytoclastic vasculitis (LCV).

Case Presentation

A 79-year-old presented to the hospital with 2-day history of a rash. The rash was purpureal and petechial and located on the trunk and bilateral upper and lower extremities. The rash was associated with itchiness and pain in the wrists, ankles, and small joints of the hands. The patient reported no changes in medication or diet, no recent upper respiratory tract or gastrointestinal infections, fever or chills, night sweats, or weight loss. The patient’s medical history consisted of thrombocytopenia about 5 years before and since then had been following up with a hematologist and underwent an extensive workup, including bone marrow biopsy without a definite diagnosis.

The patient mentioned that at the time of diagnosis the platelet count was about 90,000 but had been fluctuating between 50 and 60,000 recently. The patient also reported no history of gum bleeding, nosebleeds, hemoptysis, hematemesis, or any miscarriages. She also had difficulty voiding for 2 to 3 days but no dysuria, frequency, urgency, or incontinence.

The patient was diagnosed with a urinary tract infection (UTI) 1 day before presentation and was started on ciprofloxacin 500 mg daily for 5 days. Her home medications included diphenhydramine as needed, metoprolol, and levothyroxine 125 µg. Her medical history was significant for hypertension, bradycardia with pacemaker placement, and obstructive sleep apnea. There were no noteworthy elements in her family and social history.

Laboratory results were significant for 57,000/µL platelet count (normal range, 150,000-450,000), elevated d-dimer (6.07), < 6 mg/dL C4 (normal range, 88-201). Hemoglobin level, coagulation panel, hemolytic panel, and fibrinogen level results were unremarkable. The hepatitis panel, Lyme disease, and HIV test were negative. The peripheral blood smear showed moderate thrombocytopenia, mild monocytosis, and borderline normochromic normocytic anemia without schistocytes. The autoimmune panel to evaluate thrombocytopenia showed platelet antibody against glycoprotein (GP) IIb/IIIa, GP Ib/Ix, GP Ia/IIa, suggestive toward a diagnosis of chronic idiopathic ITP. However, the skin biopsy of the rash was indicative of LCV.

An autoimmune panel for vasculitis, including antinuclear antibody and antidouble-stranded DNA, was negative. While in the hospital, the patient completed the course of ciprofloxacin for the UTI, the rash started to fade without any intervention, and the platelet count improved to 69,000/µL. The patient was discharged after 3 days with the recommendation to follow up with her hematologist.

Pages

Recommended Reading

Best anticoagulant for minimizing bleeding risk identified
Federal Practitioner
USPSTF holds firm on postmenopausal hormone recommendations
Federal Practitioner
Uptake of high-sensitivity troponin assays lags in U.S. hospitals
Federal Practitioner
Combo thrombolytic approach fails to reduce ICH in stroke
Federal Practitioner
Puzzling, unique ECG from pig-to-human transplanted heart
Federal Practitioner
Acute heart failure risk assessment in ED improves outcomes: COACH
Federal Practitioner
Study sheds new light on RAS inhibitors’ role for advanced CKD
Federal Practitioner
New trial suggests CV benefit with EPA: RESPECT-EPA
Federal Practitioner
‘Lucid dying’: EEG backs near-death experience during CPR 
Federal Practitioner
EHR-based thromboembolism risk tool boosted prophylaxis
Federal Practitioner